Alexandre E. Escargueil

3.0k total citations
56 papers, 2.4k citations indexed

About

Alexandre E. Escargueil is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Alexandre E. Escargueil has authored 56 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 18 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Alexandre E. Escargueil's work include Cancer therapeutics and mechanisms (15 papers), DNA Repair Mechanisms (13 papers) and Microbial Natural Products and Biosynthesis (8 papers). Alexandre E. Escargueil is often cited by papers focused on Cancer therapeutics and mechanisms (15 papers), DNA Repair Mechanisms (13 papers) and Microbial Natural Products and Biosynthesis (8 papers). Alexandre E. Escargueil collaborates with scholars based in France, Brazil and United Kingdom. Alexandre E. Escargueil's co-authors include Annette K. Larsen, Andrzej Składanowski, Stéphane Orlowski, João Antônio Pêgas Henriques, Daniele G. Soares, Alexia Garrigues, Virginie Poindessous, Stéphane Martin, Jenifer Saffi and Renata Matuo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Alexandre E. Escargueil

56 papers receiving 2.3k citations

Peers

Alexandre E. Escargueil

ONCOL

Yong‐Su Zhen China

Rong‐Guang Shao China

Genevieve Housman United States

Shannon Byler United States

Elisabetta Leo United Kingdom

Julie L. Eiseman United States

Chung-Wai Shiau Taiwan

Dayong Zhai United States

Anna Long United Kingdom

Joachim Gullbo Sweden

Yong‐Su Zhen China

Alexandre E. Escargueil

1.5k ×1.1

658 ×0.7

ONCOL

255 ×0.8

356 ×1.5

115 ×0.6

Citations per year, relative to Alexandre E. Escargueil Alexandre E. Escargueil (= 1×) peers Yong‐Su Zhen

Countries citing papers authored by Alexandre E. Escargueil

Since Specialization

Citations

This map shows the geographic impact of Alexandre E. Escargueil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre E. Escargueil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre E. Escargueil more than expected).

Fields of papers citing papers by Alexandre E. Escargueil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre E. Escargueil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre E. Escargueil. The network helps show where Alexandre E. Escargueil may publish in the future.

Co-authorship network of co-authors of Alexandre E. Escargueil

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre E. Escargueil. A scholar is included among the top collaborators of Alexandre E. Escargueil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre E. Escargueil. Alexandre E. Escargueil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Escargueil, Alexandre E., et al.. (2023). Shikonin, an inhibitor of inflammasomes, inhibits Epstein-Barr virus reactivation. Antiviral Research. 217. 105699–105699. 5 indexed citations

Machado, Miriana S., Temenouga Nikolova Guecheva, Jenifer Saffi, et al.. (2023). Diphenyl ditelluride anticancer activity and DNA topoisomerase I poisoning in human colon cancer HCT116 cells. Oncotarget. 14(1). 637–649. 3 indexed citations

Biswas, Saroj Kr., et al.. (2023). Recent trend in medical imaging modalities and their applications in disease diagnosis: a review. Multimedia Tools and Applications. 83(14). 43035–43070. 62 indexed citations

Genta‐Jouve, Grégory, et al.. (2023). Azaphilones Pigments from the Fungus Penicillium hirayamae. SHILAP Revista de lepidopterología. 2(1). 31–41. 2 indexed citations

L’honoré, Aurore, Frédérique Quignon, Christophe Marchand, et al.. (2022). The C-Terminal Acidic Tail Modulates the Anticancer Properties of HMGB1. International Journal of Molecular Sciences. 23(14). 7865–7865. 2 indexed citations

Dilly, Sébastien, Patricia Abbe, Stéphanie Solier, et al.. (2021). Distinction between 2′- and 3′-Phosphate Isomers of a Fluorescent NADPH Analogue Led to Strong Inhibition of Cancer Cells Migration. Antioxidants. 10(5). 723–723. 1 indexed citations

Marchand, Christophe, Marine Vallet, Nathalie Ferrand, et al.. (2020). Secondary Metabolites from the Culture of the Marine-derived Fungus Paradendryphiella salina PC 362H and Evaluation of the Anticancer Activity of Its Metabolite Hyalodendrin. Marine Drugs. 18(4). 191–191. 11 indexed citations

Thomé, Marcos Paulo Machado, Annette K. Larsen, João Antônio Pêgas Henriques, et al.. (2019). Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation. Antiviral Research. 172. 104615–104615. 17 indexed citations

Mésange, Paul, Nathalie Ferrand, Michèle Sabbah, et al.. (2018). Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status. Clinical Cancer Research. 24(11). 2548–2558. 14 indexed citations

10.

Escargueil, Alexandre E., et al.. (2016). Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary Biology. Current Pharmaceutical Design. 22(44). 6625–6644. 5 indexed citations

11.

Chisholm, Rebecca H., Tommaso Lorenzi, Alexander Lorz, et al.. (2015). Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation. Cancer Research. 75(6). 930–939. 93 indexed citations

12.

Zang, Yi, Grégory Genta‐Jouve, Xuwen Li, et al.. (2015). Unexpected talaroenamine derivatives and an undescribed polyester from the fungus Talaromyces stipitatus ATCC10500. Phytochemistry. 119. 70–75. 11 indexed citations

13.

Lorz, Alexander, Tommaso Lorenzi, Jean Clairambault, Alexandre E. Escargueil, & Benoı̂t Perthame. (2014). Modeling the Effects of Space Structure and Combination Therapies on Phenotypic Heterogeneity and Drug Resistance in Solid Tumors. Bulletin of Mathematical Biology. 77(1). 1–22. 81 indexed citations

14.

Matuo, Renata, Fabrício G. Sousa, Diego Bonatto, et al.. (2013). ATP-dependent chromatin remodeling and histone acetyltransferases in 5-FU cytotoxicity in Saccharomyces cerevisiae. Genetics and Molecular Research. 12(2). 1440–1456. 4 indexed citations

15.

Sousa, Fabrício G., Renata Matuo, Daniele G. Soares, et al.. (2012). PARPs and the DNA damage response. Carcinogenesis. 33(8). 1433–1440. 117 indexed citations

16.

Soares, Daniele G., Miriana S. Machado, Céline J. Rocca, et al.. (2011). Trabectedin and Its C Subunit Modified Analogue PM01183 Attenuate Nucleotide Excision Repair and Show Activity toward Platinum-Resistant Cells. Molecular Cancer Therapeutics. 10(8). 1481–1489. 62 indexed citations

17.

Rocca, Céline J., Virginie Poindessous, Daniele G. Soares, et al.. (2010). The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: Implications for recognition and repair of antitumor alkylators. Biochemical Pharmacology. 80(3). 335–343. 13 indexed citations

18.

Orlowski, Stéphane, Stéphane Martin, & Alexandre E. Escargueil. (2006). P-glycoprotein and ‘lipid rafts’: some ambiguous mutual relationships (floating on them, building them or meeting them by chance?). Cellular and Molecular Life Sciences. 63(9). 1038–1059. 102 indexed citations

19.

Larsen, Annette K., Alexandre E. Escargueil, & Andrzej Składanowski. (2003). Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacology & Therapeutics. 99(2). 167–181. 332 indexed citations

20.

Larsen, Annette K., Alexandre E. Escargueil, & Andrzej Składanowski. (2000). Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacology & Therapeutics. 85(3). 217–229. 308 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact